BIOMIMETIC THERAPEUTICS, INC. 5,000,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • July 15th, 2010 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
BioMimetic Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), an aggregate of 5,000,000 shares of common stock, par value $0.001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 750,000 shares of Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”
